Patenting Nanomedicines [electronic resource] :Legal Aspects, Intellectual Property and Grant Opportunities / edited by Eliana B. Souto.
by Souto, Eliana B [editor.]; SpringerLink (Online service).
Material type:
BookPublisher: Berlin, Heidelberg : Springer Berlin Heidelberg : 2012.Description: XXIII, 457 p. 30 illus., 12 illus. in color. online resource.ISBN: 9783642292651.Subject(s): Law | Medicine | Philosophy of law | medicine -- Philosophy | Law | Private International Law, International & Foreign Law, Comparative Law | Philosophy of Medicine | Philosophy of Law | Biomedicine general | International IT and Media Law, Intellectual Property LawDDC classification: 340.9 | 340.2 Online resources: Click here to access online
In:
Springer eBooksSummary: The book focusses on the fundamental aspects of Patenting Nanomedicines applied in different “Drug Delivery and Targeting Systems”. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning. This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts – Part I is composed of the first 3 chapters, which focus on the “fundamentals” of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.
| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| K7073-7078 (Browse shelf) | Available | ||||
| Long Loan | MAIN LIBRARY | K7000-7720.22 (Browse shelf) | Available |
Close shelf browser
| Q334-342 Electronic Healthcare | TJ210.2-211.495 Electronic Healthcare | K7000-7720.22 Patenting Nanomedicines | K7073-7078 Patenting Nanomedicines | HF1351-1647 Introduction to Intercultural Economics | TK5105.5-5105.9 Advanced Computing, Networking and Security | RL1-803 Cutaneous Manifestations of Child Abuse and Their Differential Diagnosis |
The book focusses on the fundamental aspects of Patenting Nanomedicines applied in different “Drug Delivery and Targeting Systems”. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning. This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts – Part I is composed of the first 3 chapters, which focus on the “fundamentals” of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.
There are no comments for this item.